What are the Side Effects of Aromatase Inhibitors | Susan G. Komen® - breast cancer tamoxifen aromatase

Category

Aromatase Inhibitors - Side Effects | Susan G. Komen® breast cancer tamoxifen aromatase


year breast cancer mortality was lower with aromatase inhibitors than tamoxifen (12·1% vs 14·2%; RR 0·85, 0·75–0·96; 2p=0·). In the.

Keywords: Breast cancer, aromatase inhibitors, premenopausal women Compared with no endocrine therapy, tamoxifen was associated with.

Keywords: AI, breast cancer, comparative effectiveness, tamoxifen primarily tamoxifen (TAM) and aromatase inhibitors (AIs), are the most.